Bionano Genomics to Host Strategy Day on February 2, 2023 in New York City
06 Janeiro 2023 - 10:00AM
Bionano Genomics, Inc. (BNGO) today announced that it will
host its first-ever Strategy Day on Thursday, February 2nd, 2023,
at the Nasdaq MarketSite in New York City, starting at 1:30 PM ET.
The event will include presentations from members of the company's
leadership team and panel discussions featuring key opinion leaders
in basic and clinical research areas including cancer, genetic
disorders and cell bioprocessing. Bionano panel members will also
participate in a Q&A discussion with the audience.
The event will include a live webcast which will be archived and
available for replay after the event. Please visit the "Investors"
section of the company website at https://ir.bionanogenomics.com/
to register for the webcast and for additional information on the
event.
About Bionano Genomics
Bionano Genomics is a provider of genome analysis solutions
that can enable researchers and clinicians to reveal answers to
challenging questions in biology and medicine. The Company’s
mission is to transform the way the world sees the genome through
OGM solutions, diagnostic services and software. The Company offers
OGM solutions for applications across basic, translational and
clinical research. Through its Lineagen,
Inc. d/b/a Bionano Laboratories business, the
Company also provides diagnostic testing for patients with clinical
presentations consistent with autism spectrum disorder and other
neurodevelopmental disabilities. The Company also offers an
industry-leading, platform-agnostic software solution, which
integrates next-generation sequencing and microarray data designed
to provide analysis, visualization, interpretation and reporting of
copy number variants, single-nucleotide variants and absence of
heterozygosity across the genome in one consolidated view.
For more information,
visit www.bionanogenomics.com, www.bionanolaboratories.com or www.biodiscovery.com
CONTACTSCompany Contact:Erik Holmlin,
CEOBionano Genomics, Inc.+1 (858)
888-7610eholmlin@bionanogenomics.com
Investor Relations:Amy ConradJuniper Point+1 (858)
366-3243amy@juniper-point.com
Bionano Genomics (NASDAQ:BNGO)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024
Bionano Genomics (NASDAQ:BNGO)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024